You are here

A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Anaheim, California, 92801 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Sensorineural Hearing Loss
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects must have a current diagnosis of age related sensorineural hearing loss in
the range of 30-60 dB, averaged over 2 and 4 kHz in at least one ear.

- Subjects must have symmetric hearing loss

- Subjects who can read, speak and comprehend English.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who have a history of sudden hearing loss and history or diagnosis of rapidly
progressive idiopathic hearing loss

- Subjects who have hearing disorders other than age related sensorineural hearing loss

- Subjects with moderate or greater tinnitus

- Pregnant females; breastfeeding females; females of childbearing potential

NCT01518920
Pfizer
Completed
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now